Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

What "newest" means here

The most recent study in this library is dated 2026-11-01 (Paths of Aging Minds: Health Journeys of Older Adults with Mild Cognitive Impairment). This is our summary library, not a news wire — it is added to in batches, so the newest entry may not be the newest paper published anywhere.

Entries are sorted strictly by publication date, newest first. 26489 of the 27380 entries carry a full day-level date. 65 have no date recorded at all and are placed by publication year, at the start of that year; those are marked "no date recorded" below so you can see where the ordering is a best effort rather than a fact.

Prefer a reader? Subscribe to the Atom feed. Want them sorted by subject or by score instead? Browse the research library.

Showing 25,276–25,300 of 27,380 studies, newest first · page 1012 of 1096.

January 2001 25

  1. 2001-01-01
  2. 2001-01-01

    Treatment of Mania in Dementia With Electroconvulsive Therapy

    ✓ Peer-reviewed How common it is Psychopharmacology Bulletin

    Key finding: Because it is so highly associated with behavioral agitation, mania has a significant impact on patient management, and can often lead to the institutionalization of difficult patients. +2 more findings

  3. 2001-01-01

    The Incidence of Vascular Dementia in Canada: A Comparison with Europe and East Asia

    ✓ Peer-reviewed Risk factors Neuroepidemiology

    Key finding: Vascular dementia (VaD) is the second commonest subtype of dementia after Alzheimer's disease (AD).

  4. 2001-01-01

    The morphological phenotype of beta-amyloid plaques and associated neuritic changes in Alzheimer's disease

    ✓ Peer-reviewed Brain tissue and pathology Neuroscience

    Key finding: Plaques with a spherical profile were defined as either diffuse, fibrillar or dense-cored using Thioflavin S staining or immunolabelling for beta-amyloid. +3 more findings

  5. 2001-01-01

    Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales. Neuropathology Group of the Medical Research Council Cognitive Function and Ageing Study (MRC CFAS)

    ✓ Peer-reviewed Brain tissue and pathology Lancet (London, England)

    Key finding: We have undertaken a large unselected, community-based neuropathology study in an elderly (70-103 years) UK population in relation to prospectively evaluated dementia status. +3 more findings

  6. 2001-01-01

    Blood pressure and risk of dementia: results from the Rotterdam study and the Gothenburg H-70 Study

    ✓ Peer-reviewed Long-term cohort studies Dementia and geriatric cognitive disorders

    Key finding: The association between blood pressure and dementia is debated. +3 more findings

  7. 2001-01-01

    Cortical change in Alzheimer's disease detected with a disease-specific population-based brain atlas

    ✓ Peer-reviewed Cognitive tests and assessment Cerebral cortex (New York, N.Y. : 1991)

    Key finding: New computational approaches were used to: (i) distinguish variations in gray matter distribution from variations in gyral patterns; (ii) encode these variations in a brain atlas (n = 46); (iii) create detailed maps localizing gray matter differences across groups. +3 more findings

  8. 2001-01-01

    Codeposition of cystatin C with amyloid-beta protein in the brain of Alzheimer disease patients

    ✓ Peer-reviewed Risk genes beyond APOE Journal of neuropathology and experimental neurology

    Key finding: No evidence of cerebral hemorrhage was observed in any of the brains studied. +3 more findings

  9. 2001-01-01

    Tau filament formation in transgenic mice expressing P301L tau

    ✓ Peer-reviewed Lewy body dementia The Journal of biological chemistry

    Key finding: To determine whether P301L is associated with fibril formation in mice, we expressed the longest human tau isoform, human tau40, with this mutation in transgenic mice by using the neuron-specific mouse Thy1.2 promoter. +2 more findings

  10. 2001-01-01

    Proteasomal function is impaired in substantia nigra in Parkinson's disease

    ✓ Peer-reviewed Lewy body dementia Neuroscience letters

    Key finding: The accumulation of alpha-synuclein, ubiquitin and other proteins in Lewy bodies in degenerating dopaminergic neurones in substantia nigra in idiopathic Parkinson's disease (PD) suggest that inhibition of normal/abnormal protein degradation may contribute to neuronal death. +1 more finding

  11. 2001-01-01

    Neurodegenerative tauopathies

    ✓ Peer-reviewed Lewy body dementia Annual review of neuroscience

    Key finding: Nonetheless, different members of the same kindred often exhibit diverse FTDP-17 syndromes, which suggests that additional genetic or epigenetic factors influence the phenotypic manifestations of neurodegenerative tauopathies.

  12. 2001-01-01

    Glial-neurotrophic mechanisms in Down syndrome

    ✓ Peer-reviewed Down syndrome and Alzheimer's Journal of neural transmission. Supplementum

    Key finding: The result is a small but slowly increasing deficit in activity-dependent support by glia cells which produces a gradually increasing abnormality of cortical and subcortical, perhaps especially cholinergic, function.

  13. 2001-01-01

    Carbohydrate handling enzymes in fetal Down syndrome brain

    ✓ Peer-reviewed Down syndrome and Alzheimer's Journal of neural transmission. Supplementum

    Key finding: We observed comparable levels of phosphoglycerate mutase, phosphoglycerate kinase 1; fructose-biphosphate aldolase A, fructose bisphosphate aldolase C; ribose-phosphate pyrophosphokinase 1; D-phosphoglycerate dehydrogenase, 6-phosphogluconolactonase; aflatoxin B1 aldehyde reductase 1, aldose reductase; inosine-5'-monophosphate dehydrogenase 2; galactokinase, in brain of fetal controls and DS. +1 more finding

  14. 2001-01-01

    The brain in Down syndrome

    ✓ Peer-reviewed Down syndrome and Alzheimer's Journal of neural transmission. Supplementum

    Key finding: Down syndrome (trisomy 21) is a genetic disease with developmental brain abnormalities resulting in early mental retardation and precocious, age dependent Alzheimer-type neurodegeneration. +2 more findings

  15. 2001-01-01

    Unaltered expression of Fas (CD95/APO-1), caspase-3, Bcl-2 and annexins in brains of fetal Down syndrome: evidence against increased apoptosis

    ✓ Peer-reviewed Down syndrome and Alzheimer's Journal of neural transmission. Supplementum

    Key finding: Accumulating evidence indicates that enhanced apoptosis (programmed cell death) in Down syndrome (DS) may play a role in mental retardation and precocious neurodegeneration of the Alzheimer-type. +2 more findings

  16. 2001-01-01

    Down syndrome: progress in research

    ✓ Peer-reviewed Down syndrome and Alzheimer's Mental retardation and developmental disabilities research reviews

    Key finding: This review discusses the research published in the last five years on the behavioral, genetic, medical, and neuroscience aspects of Down syndrome. +1 more finding

  17. 2001-01-01

    Superoxide dismutase SOD1, encoded on chromosome 21, but not SOD2 is overexpressed in brains of patients with Down syndrome

    ✓ Peer-reviewed Down syndrome and Alzheimer's Journal of investigative medicine : the official publication of the American Federation for Clinical Research

    Key finding: Increased SOD-1 levels in patients with DS may reflect the overexpression by the trisomic state, as a response to the oxidative stress, as has been proposed in DS by several authors.

  18. 2001-01-01
  19. 2001-01-01

    HIV-associated neurologic disease incidence changes:: Multicenter AIDS Cohort Study, 1990-1998

    ✓ Peer-reviewed How common it is Neurology

    Key finding: This study examined the temporal trends in the incidence rates of HIV dementia, cryptococcal meningitis, toxoplasmosis, progressive multifocal leukoencephalopathy, and CNS lymphoma from January 1990 to December 1998 in the Multicenter AIDS Cohort Study. +2 more findings

  20. 2001-01-01

    Classification criteria for mild cognitive impairment: a population-based validation study

    ✓ Peer-reviewed How common it is Neurology

    Key finding: MCI criteria perform poorly when applied to a representative population sample.

  21. 2001-01-01

    Prevalence of cerebral white matter lesions in elderly people: a population based magnetic resonance imaging study. The Rotterdam Scan Study

    ✓ Peer-reviewed How common it is Journal of neurology, neurosurgery, and psychiatry

    Key finding: The prevalence and the degree of cerebral white matter lesions increased with age. +1 more finding

  22. 2001-01-01

    Anticholinergic effects of medication in elderly patients

    ✓ Peer-reviewed Caregiving The Journal of clinical psychiatry

    Key finding: The toxicity is often the result of the cumulative anticholinergic burden of multiple prescription medications and metabolites rather than of a single compound.

  23. 2001-01-01

    Clinical validity of the 'mini-mental state' for Spanish speaking communities

    ✓ Peer-reviewed Getting a diagnosis Neuropsychologia

    Key finding: The test was administered to 450 subjects (253 control volunteers, 86 mild memory/cognitive impairment without dementia subjects - CIWD and 111 Alzheimer's Disease patients - AD). +4 more findings

  24. 2001-01-01

    Stability of the preclinical episodic memory deficit in Alzheimer's disease

    ✓ Peer-reviewed Getting a diagnosis Brain : a journal of neurology

    Key finding: These results indicate that Alzheimer's disease is characterized by a long preclinical period during which episodic memory deficits are detectable. +1 more finding

  25. 2001-01-01

    Validation of the Delirium Rating Scale-revised-98: comparison with the delirium rating scale and the cognitive test for delirium

    ✓ Peer-reviewed Getting a diagnosis The Journal of neuropsychiatry and clinical neurosciences

    Key finding: Mean and median DRS-R-98 scores significantly (P<0.001) distinguished delirium from each other group.

Browse the library by subject, with the full score breakdown →